158 related articles for article (PubMed ID: 38713753)
1. Advancements in Aptamer-Driven DNA Nanostructures for Precision Drug Delivery.
Safarkhani M; Ahmadi S; Ipakchi H; Saeb MR; Makvandi P; Ebrahimi Warkiani M; Rabiee N; Huh Y
Adv Sci (Weinh); 2024 May; ():e2401617. PubMed ID: 38713753
[TBL] [Abstract][Full Text] [Related]
2. Precision-Guided Missile-Like DNA Nanostructure Containing Warhead and Guidance Control for Aptamer-Based Targeted Drug Delivery into Cancer Cells in Vitro and in Vivo.
Ouyang C; Zhang S; Xue C; Yu X; Xu H; Wang Z; Lu Y; Wu ZS
J Am Chem Soc; 2020 Jan; 142(3):1265-1277. PubMed ID: 31895985
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of dual-functional composite magnetic nanomaterials modified with different metals/aptamers and their performance in exosome enrichment].
Zhang W; Lu R; Zhang L
Se Pu; 2021 Oct; 39(10):1128-1136. PubMed ID: 34505435
[TBL] [Abstract][Full Text] [Related]
4. Aptamer-based targeted delivery systems for cancer treatment using DNA origami and DNA nanostructures.
Jabbari A; Sameiyan E; Yaghoobi E; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Int J Pharm; 2023 Nov; 646():123448. PubMed ID: 37757957
[TBL] [Abstract][Full Text] [Related]
5. Aptamer-Functionalized Hybrid Nanostructures for Sensing, Drug Delivery, Catalysis and Mechanical Applications.
Vázquez-González M; Willner I
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670386
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-Modified Tetrahedral DNA Nanostructures as Drug Delivery System for Cancer Targeted Therapy.
Zhao R; Bai Y; Guo Y; Feng F; Shuang S
Macromol Biosci; 2024 Apr; 24(4):e2300420. PubMed ID: 38088938
[TBL] [Abstract][Full Text] [Related]
7. DNA Aptamers for the Functionalisation of DNA Origami Nanostructures.
Sakai Y; Islam MS; Adamiak M; Shiu SC; Tanner JA; Heddle JG
Genes (Basel); 2018 Nov; 9(12):. PubMed ID: 30477184
[TBL] [Abstract][Full Text] [Related]
8. Self-Assembled DNA Nanocentipede as Multivalent Drug Carrier for Targeted Delivery.
Li W; Yang X; He L; Wang K; Wang Q; Huang J; Liu J; Wu B; Xu C
ACS Appl Mater Interfaces; 2016 Oct; 8(39):25733-25740. PubMed ID: 27622459
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
[TBL] [Abstract][Full Text] [Related]
10. Aptamers as the chaperones (Aptachaperones) of drugs-from siRNAs to DNA nanorobots.
Citartan M; Kaur H; Presela R; Tang TH
Int J Pharm; 2019 Aug; 567():118483. PubMed ID: 31260780
[TBL] [Abstract][Full Text] [Related]
11. Aptamer-Modified Tetrahedral DNA Nanostructure for Tumor-Targeted Drug Delivery.
Li Q; Zhao D; Shao X; Lin S; Xie X; Liu M; Ma W; Shi S; Lin Y
ACS Appl Mater Interfaces; 2017 Oct; 9(42):36695-36701. PubMed ID: 28991436
[TBL] [Abstract][Full Text] [Related]
12. Self-assembly of DNA nanostructure containing cell-specific aptamer as a precise drug delivery system for cancer therapy in non-small cell lung cancer.
Wang N; Yu C; Xu T; Yao D; Zhu L; Shen Z; Huang X
J Nanobiotechnology; 2022 Nov; 20(1):486. PubMed ID: 36403038
[TBL] [Abstract][Full Text] [Related]
13. Multivalent aptamer-modified tetrahedral DNA nanocage demonstrates high selectivity and safety for anti-tumor therapy.
Han X; Jiang Y; Li S; Zhang Y; Ma X; Wu Z; Wu Z; Qi X
Nanoscale; 2018 Dec; 11(1):339-347. PubMed ID: 30534748
[TBL] [Abstract][Full Text] [Related]
14. Aptamer-modified tetrahedral DNA nanostructure-immobilized liposome for specific gene delivery and potential cancer theragnostic.
Lim DY; Hwang BH
Biotechnol J; 2024 Jan; 19(1):e2300156. PubMed ID: 37837335
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Functional Properties of Three DNA Origami Nanostructures as Doxorubicin Carriers to Breast Cancer Cells.
Udomprasert A; Wootthichairangsan C; Duangrat R; Chaithongyot S; Zhang Y; Nixon R; Liu W; Wang R; Ponglikitmongkol M; Kangsamaksin T
ACS Appl Bio Mater; 2022 May; 5(5):2262-2272. PubMed ID: 35500214
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges.
He F; Wen N; Xiao D; Yan J; Xiong H; Cai S; Liu Z; Liu Y
Curr Med Chem; 2020; 27(13):2189-2219. PubMed ID: 30295183
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
[TBL] [Abstract][Full Text] [Related]
18. Aptamer-Functionalized DNA Nanostructures for Biological Applications.
Fu X; Peng F; Lee J; Yang Q; Zhang F; Xiong M; Kong G; Meng HM; Ke G; Zhang XB
Top Curr Chem (Cham); 2020 Feb; 378(2):21. PubMed ID: 32030541
[TBL] [Abstract][Full Text] [Related]
19. Rationally Designed DNA-Origami Nanomaterials for Drug Delivery In Vivo.
Jiang Q; Liu S; Liu J; Wang ZG; Ding B
Adv Mater; 2019 Nov; 31(45):e1804785. PubMed ID: 30285296
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-engineered (nano)materials for theranostic applications.
Rabiee N; Chen S; Ahmadi S; Veedu RN
Theranostics; 2023; 13(15):5183-5206. PubMed ID: 37908725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
